These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 31406341)

  • 1. Molecular genetic framework underlying pulmonary arterial hypertension.
    Southgate L; Machado RD; Gräf S; Morrell NW
    Nat Rev Cardiol; 2020 Feb; 17(2):85-95. PubMed ID: 31406341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genes in pediatric pulmonary arterial hypertension and the most promising
    Dai L; Du L
    Front Genet; 2022; 13():961848. PubMed ID: 36506323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension.
    Fazal S; Bisserier M; Hadri L
    Cells; 2021 Mar; 10(3):. PubMed ID: 33805595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
    Zhu N; Swietlik EM; Welch CL; Pauciulo MW; Hagen JJ; Zhou X; Guo Y; Karten J; Pandya D; Tilly T; Lutz KA; Martin JM; Treacy CM; Rosenzweig EB; Krishnan U; Coleman AW; Gonzaga-Jauregui C; Lawrie A; Trembath RC; Wilkins MR; ; ; ; ; Morrell NW; Shen Y; Gräf S; Nichols WC; Chung WK
    Genome Med; 2021 May; 13(1):80. PubMed ID: 33971972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Heterozygous
    Bohnen MS; Roman-Campos D; Terrenoire C; Jnani J; Sampson KJ; Chung WK; Kass RS
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28889099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX17 Loss-of-Function Mutation Underlying Familial Pulmonary Arterial Hypertension.
    Wang TM; Wang SS; Xu YJ; Zhao CM; Qiao XH; Yang CX; Liu XY; Yang YQ
    Int Heart J; 2021 May; 62(3):566-574. PubMed ID: 33952808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic Characterization of
    Hadinnapola C; Bleda M; Haimel M; Screaton N; Swift A; Dorfmüller P; Preston SD; Southwood M; Hernandez-Sanchez J; Martin J; Treacy C; Yates K; Bogaard H; Church C; Coghlan G; Condliffe R; Corris PA; Gibbs S; Girerd B; Holden S; Humbert M; Kiely DG; Lawrie A; Machado R; MacKenzie Ross R; Moledina S; Montani D; Newnham M; Peacock A; Pepke-Zaba J; Rayner-Matthews P; Shamardina O; Soubrier F; Southgate L; Suntharalingam J; Toshner M; Trembath R; Vonk Noordegraaf A; Wilkins MR; Wort SJ; Wharton J; ; Gräf S; Morrell NW
    Circulation; 2017 Nov; 136(21):2022-2033. PubMed ID: 28972005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease.
    Zhu N; Welch CL; Wang J; Allen PM; Gonzaga-Jauregui C; Ma L; King AK; Krishnan U; Rosenzweig EB; Ivy DD; Austin ED; Hamid R; Pauciulo MW; Lutz KA; Nichols WC; Reid JG; Overton JD; Baras A; Dewey FE; Shen Y; Chung WK
    Genome Med; 2018 Jul; 10(1):56. PubMed ID: 30029678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension.
    Zhu N; Pauciulo MW; Welch CL; Lutz KA; Coleman AW; Gonzaga-Jauregui C; Wang J; Grimes JM; Martin LJ; He H; ; Shen Y; Chung WK; Nichols WC
    Genome Med; 2019 Nov; 11(1):69. PubMed ID: 31727138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
    He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
    Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic basis of pulmonary arterial hypertension.
    Ma L; Chung WK
    Hum Genet; 2014 May; 133(5):471-9. PubMed ID: 24442418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs.
    Zahid KR; Raza U; Chen J; Raj UJ; Gou D
    Cardiovasc Res; 2020 Oct; 116(12):1937-1947. PubMed ID: 32109276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes that drive the pathobiology of pediatric pulmonary arterial hypertension.
    Welch CL; Austin ED; Chung WK
    Pediatr Pulmonol; 2021 Mar; 56(3):614-620. PubMed ID: 31917901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.
    Bisserier M; Mathiyalagan P; Zhang S; Elmastour F; Dorfmüller P; Humbert M; David G; Tarzami S; Weber T; Perros F; Sassi Y; Sahoo S; Hadri L
    Circulation; 2021 Jul; 144(1):52-73. PubMed ID: 34078089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension.
    Han Y; Ali MK; Dua K; Spiekerkoetter E; Mao Y
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.